Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Results from Pivotal Phase 3 ATTACK Trial of Investigational Sulbactam-Durlobactam for Treatment of Serious Infections Caused by Acinetobacter Published
Innoviva Specialty Therapeutics, a subsidiary of Innoviva, focused on delivering innovative therapies in critical care […]
Nexus Pharmaceuticals Announces Appointment of New Board Members
Nexus Pharmaceuticals, a privately-owned U.S.-based healthcare company, has announced the appointment of Edgar Lee and […]
Synthego Opens State-of-the-Art GMP Guide RNA Manufacturing Facility to Enable CRISPR Genomic Medicines
Synthego, a leading provider of genome engineering solutions, announced today the opening of its state-of-the-art […]
Kintor Pharma Announces Successful Completion of Phase II Clinical Trial of KX-826 for Treatment of Androgenetic Alopecia
Kintor Pharmaceutical, a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced that […]
Cellular Origins Partners with ScaleReady to Simplify, Standardise, and Automate Cell Therapy Manufacturing
Cellular Origins, a TTP Company focused on enabling scalable, cost-effective and efficient manufacture of cell […]
Dr. Jacqueline Sneddon, BSAC, on Antibiotics
At the 33rd ECCMID event, we caught up with Dr. Jacqueline Sneddon, the Programmes Manager […]
Patient Discovery Partners with AmerisourceBergen for Cancer Care Equity
Patient Discovery Solutions, a leader in health equity solutions that harness the power of patient-centered […]
Mission Bio Develops Single-Cell Solution to Address Challenges in Genome Editing
Mission Bio, the single-cell DNA and multi-omics company, announced today the Tapestri® Genome Editing Solution, […]
Pavel Dřevínek, an Academic Researcher, on Services for Sepsis
At the 33rd ECCMID event, we caught up with Pavel Dřevínek, an academic researcher at […]
Niklas Prager Appointed New CEO of SmartCella
SmartCella Holding AB has today announced that Niklas Prager has been appointed as the new […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more